istaroxime
istaroxime: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | Phase 1/Phase 2 |
Clinical Trials (1)
A Multicenter, Randomized, Placebo-Controlled, Parallel Group Trial on the Safety and Efficacy of Istaroxime for Cardiogenic Shock SCAI Stage C
Frequently asked questions
Who is developing istaroxime?
istaroxime is being developed by WINDTREE THERAPEUTICS INC /DE/.
How many clinical trials involve istaroxime?
BioSniper tracks 1 clinical trial involving istaroxime.
Get deeper analysis on istaroxime
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis